Gaenzle Christopher L 4

4 · PRA Health Sciences, Inc. · Filed Jun 21, 2021

Form 4

Period: 2021-06-17

EVP, Chief Admin Officer & GC

Transactions

Exercise/Conversion
Stock Options (Right to Buy)
2021-06-17−4,326→ 17,114 total
Exercise: $103.30Exp: 2030-06-01→ Common Stock (4,326 underlying)
Sale
Common Stock
2021-06-17$169.75/sh−692$117,467→ 34,500 total
Exercise/Conversion
Common Stock
2021-06-17$101.42/sh+18,958$1,922,720→ 57,671 total
Exercise/Conversion
Common Stock
2021-06-17$95.94/sh+4,213$404,195→ 38,713 total
Exercise/Conversion
Common Stock
2021-06-17$103.30/sh+4,326$446,876→ 61,997 total
Exercise/Conversion
Stock Options (Right to Buy)
2021-06-17−18,958→ 37,500 total
Exercise: $101.42Exp: 2028-08-10→ Common Stock (18,958 underlying)
Sale
Common Stock
2021-06-17$167.40/sh−1,300$217,620→ 60,697 total
Sale
Common Stock
2021-06-17$168.06/sh−13,391$2,250,491→ 47,306 total
Sale
Common Stock
2021-06-17$169.41/sh−12,114$2,052,233→ 35,192 total
Exercise/Conversion
Stock Options (Right to Buy)
2021-06-17−4,213→ 16,666 total
Exercise: $95.94Exp: 2029-08-13→ Common Stock (4,213 underlying)

Footnotes (8)

[F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $166.72 to $167.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2), (3), (4) and (5) to this Form 4.
[F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $167.72 to $168.67, inclusive.
[F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $168.73 to $169.70, inclusive.
[F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $169.73 to $169.79, inclusive.
[F6]The option vests in three equal annual installments of 8,334 beginning on August 13, 2020.
[F7]The option vests in four equal annual installments of 18,750 beginning on August 10, 2019.
[F8]The option vests in three equal annual installments of 8,556 beginning on June 1, 2021.

Documents

1 file